The biomarker data demonstrate significant AlaGln effects on peritoneal IL-8 levels in patients with a history of peritonitis and with above-average levels of effluent IL-8 (indicating ongoing peritoneal inflammation), likely reflecting attenuated sterile peritoneal inflammation [64, 65]. This evidence concerns the gene CXCL8 and peritonitis.